1·Plasminogen activator inhibitor-1 (PAI-1) is the main regulator of the fibrinolytic system.
血浆纤溶酶原激活物抑制剂(PAI) - 1是纤溶系统的主要调控因子。
2·Conclusion Captopril enhances the endogenous fibrinolytic system in patients with AMI and UAP.
结论卡托普利增强冠心病患者内源性纤溶系统活性。
3·Objective To study the changes in fibrinolytic system after 8-week swimming training under different loads in rats.
目的通过对大鼠进行8周不同负荷的游泳训练，研究运动对大鼠纤溶系统的影响。
4·Objective To investigate effects of fibrinolytic system upon deep venous thrombosis, focused on PLG, t-PA and PAI-1.
目的以纤溶酶原、t - PA和PAI - 1为轴心，探讨纤溶系统对深静脉血栓形成(DVT)的影响。
5·CONCLUSIONS Ultraviolet irradiation may activate fibrinolytic system and solve the thrombus near vascular anastomosis.
结论紫外线照射可激活纤溶系统，溶解血管吻合口局部血栓。
6·Conclusion it was suggested that the abnormal activities of fibrinolytic system is associated with insulin resistance in CHD.
结论冠心病患者的纤溶系统活性异常与胰岛素抵抗有关。
7·Objective To explore the effects of Batroxobin on coagulation and fibrinolytic system in patients with acute cerebral infarction.
目的探讨东菱克栓酶治疗急性脑梗死对凝血与纤溶系统的影响及意义。
8·The activator protein for the fibrinolytic system has wide application prospects and favorable economic value and social benefits.
本发明具有广阔的应用前景，具有良好的经济价值和社会效益。
9·Objective To explore the effects of Batroxobin on coagulation and fibrinolytic system in the patients with acute cerebral infarction.
目的探讨急性脑梗塞患者用东菱克栓酶治疗对其凝血与纤溶系统的影响。
10·Conclusion in the early stage of cerebral infarction, the lower patients' fibrinolytic system activity was, the poorer prognosis was.
结论脑梗死患者病初纤溶活性越低，预后越差。